Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Cyclo Therapeutics Inc (CYTH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cyclo Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.450 -0.070    -4.61%
16:00:59 - Closed. Currency in USD ( Disclaimer )
After Hours
1.450
-0.000
-0.000%
19:56:00 - Real-time Data
  • Volume: 75,624
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.450 - 1.590
Type:  Equity
Market:  United States
Cyclo Therapeutics 1.450 -0.070 -4.61%

Cyclo Therapeutics Inc Company Profile

 
Get an in-depth profile of Cyclo Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

9

Equity Type

ORD

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company’s lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer’s disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida.

Contact Information

Address 6714 NW 16th Street Suite B
Gainesville, 32653
United States
Phone 386 418 8060
Fax 321 244 8351

Top Executives

Name Age Since Title
F. Patrick Ostronic 65 2014 Independent Vice Chairman
Randall M. Toig 70 2018 Independent Director
Markus Walter Sieger 55 2014 Independent Chairman
N. Scott Fine 64 2014 CEO & Director
Gerald F. Cox 62 2021 Member of Scientific Advisory Board
Sharon H. Hrynkow 62 2014 Co-Chairman of Scientific Advisory Board
C. E Strattan 76 1990 Founder & Director
Jeffrey L. Tate 64 2010 COO, Chief Quality Officer & Director
William Conkling 51 2023 Independent Director
Benny Liu - 2015 Member of Scientific Advisory Board
William S. Shanahan 84 2016 Independent Director
Rita R. Colwell - - Co-Chair of Scientific Advisory Board
Caroline Hastings - 2015 Member of Scientific Advisory Board
Vivien Wong 67 2023 Independent Director
Shawn M. Cross 56 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CYTH Comments

Write your thoughts about Cyclo Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email